These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 814911)

  • 1. [Influence of disodium etidronate (EHDP) on plasma and urinary levels of sodium and potassium in humans].
    Gennari C; Orlandini GA; Nuti R; Francini G
    Boll Soc Ital Biol Sper; 1975 Jul; 51(14):873-7. PubMed ID: 814911
    [No Abstract]   [Full Text] [Related]  

  • 2. Paget's disease of bone. Experience with a diphosphonate (disodium etidronate) in treatment.
    Smith R; Russell RG; Bishop MC; Woods CG; Bishop M
    Q J Med; 1973 Apr; 42(166):235-56. PubMed ID: 4206518
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial: Diphosphonate treatment in bone disease.
    Fleisch H; Bonjour JP
    N Engl J Med; 1973 Dec; 289(26):1419-20. PubMed ID: 4201877
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of the therapeutic effects of disodium etidronate (EHDP) on hypercholesteremia and on hypertriglyceridemia].
    Gennari C; Picchi M; Pepi F
    Boll Soc Ital Cardiol; 1975; 20(10):1145-53. PubMed ID: 825131
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diphosphonate (disodium etidronate) lowers cholesterol and total lipid levels in the blood of humans].
    Caniggia A; Gennari C; Picchi M
    Boll Soc Ital Biol Sper; 1974 Sep; 50(17):1416-22. PubMed ID: 4218488
    [No Abstract]   [Full Text] [Related]  

  • 6. Results of prolonged treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1, 1-diphosphonate (EHDP).
    De Vries HR; Bijvoet OL
    Neth J Med; 1974; 17(6):281-98. PubMed ID: 4280525
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of a diphosphonate (disodium etidronate: EHDP) on phosphate metabolism in Paget's disease of bone, primary hyperparathyroidism and type I hypophosphataemic rickets.
    Walton RJ; Smith R; Russell RG
    Calcif Tissue Res; 1976 Aug; 21 Suppl():339-43. PubMed ID: 182335
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in the renal and extrarenal handling of phosphate induced by disodium etidronate (EHDP) in man.
    Walton RJ; Russell RG; Smith R
    Clin Sci Mol Med; 1975 Jul; 49(1):45-56. PubMed ID: 807449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proceedings: Some effects of disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP) on calcium metabolism in man.
    Walton RJ; Russell RG; Smith R; Warner G
    Clin Sci Mol Med; 1974 Sep; 47(3):13P-14P. PubMed ID: 4213811
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of etidronate disodium (EHDP) on calcium oxalate renal stones induced by synthetic 1 alpha(OH) vitamin D3 and ethylene glycol in rats].
    Kawamura J; Nonomura M; Okada Y; Yoshida O; Takashima M; Itokawa Y
    Hinyokika Kiyo; 1985 May; 31(5):749-62. PubMed ID: 3931444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sodium etidronate (EHDP) and osteoporosis].
    Nuti R; Righi G; Turchetti V; Vattimo A
    Clin Ter; 1981 Oct; 99(1):33-42. PubMed ID: 6171376
    [No Abstract]   [Full Text] [Related]  

  • 12. Failure of disodium etidronate in calcinosis due to dermatomyositis and scleroderma.
    Metzger AL; Singer FR; Bluestone R; Pearson CM
    N Engl J Med; 1974 Dec; 291(24):1294-6. PubMed ID: 4215021
    [No Abstract]   [Full Text] [Related]  

  • 13. Etidronate disodium in postmenopausal osteoporosis.
    Heaney RP; Saville PD
    Clin Pharmacol Ther; 1976 Nov; 20(5):593-604. PubMed ID: 824086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical drug appraisal: etidronate intermittent cyclic therapy for postmenopausal osteoporosis.
    Miller PD
    Br J Clin Pract; 1996; 50(1):23-31. PubMed ID: 8729598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myositis ossificans progressiva. Clinical features of eight patients and their response to treatment.
    Smith R; Russell RG; Woods CG
    J Bone Joint Surg Br; 1976 Feb; 58(1):48-57. PubMed ID: 818090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of 10 cases of symptomatic Paget's disease with etidronate (EHDP)].
    Jung A; Mermillod B; Schenk R; Courvoisier B; Burkhardt P; Epiney J; Fleisch
    Schweiz Med Wochenschr; 1976 Nov; 106(48):1667-73. PubMed ID: 827810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disodium etidronate in the prevention of postoperative recurrence of heterotopic ossification in spinal-cord injury patients.
    Stover SL; Niemann KM; Miller JM
    J Bone Joint Surg Am; 1976 Jul; 58(5):683-8. PubMed ID: 819446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diphosphonate therapy in nephrocalcinosis.
    McCredie DA; Powell HR; Rotenberg E
    Br J Urol; 1976 Apr; 48(2):93-100. PubMed ID: 821572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disodium etidronate therapy for dystrophic cutaneous calcification.
    Rabens SF; Bethune JE
    Arch Dermatol; 1975 Mar; 111(3):357-61. PubMed ID: 804294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of disodium etidronate (EHDP) on bone ingrowth in a porous material.
    Rivero DP; Skipor AK; Singh M; Urban RM; Galante JO
    Clin Orthop Relat Res; 1987 Feb; (215):279-86. PubMed ID: 3100123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.